Pharma Nobis
United States 100 employees Updated 9 July 2026
Pharma Nobis is a contract manufacturer based in United States. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 25 July 2025 as VAI.
1
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 25 July 2025 VAI US FDA
- 13 March 2020 OAI US FDA
- 7 August 2018 NAI US FDA
- 1 July 2015 OAI US FDA
- 24 July 2013 VAI US FDA
- 16 March 2012 OAI US FDA
- 29 April 2011 VAI US FDA
- 26 March 2010 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Texarkana, United States | 1611206 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Pharma Nobis comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 25 July 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates